811 material Form 8-K filings that 685 companies we cover made with the SEC in April 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Wyndham reported first-quarter 2025 results on April 30, 2025, with diluted EPS of $0.78 versus $0.19 a year earlier and fee-related and other revenues of $316 million, up 4%. The company also lowered its full-year 2025 outlook, citing a softer-than-expected RevPAR environment, with global RevPAR growth now expected at (2%) to 1% versus 2% to 3% previously. For shareholders, higher first-quarter earnings are offset by a weaker expected full-year outlook.
Diluted EPS was $0.78 versus $0.19; adjusted diluted EPS rose 10% to $0.86
Fee-related and other revenues rose 4% to $316 million from $304 million
2025 adjusted EBITDA outlook is $730 million to $745 million, down from $745 million to $755 million
2025 adjusted diluted EPS outlook is $4.57 to $4.74, down from $4.66 to $4.78
Magnolia Oil & Gas reported first quarter 2025 net income of $106.6 million, or $0.54 per diluted share, up from $97.6 million, or $0.46, a year earlier. The company raised its full-year 2025 production growth guidance to 7% to 9% from 5% to 7%, and lowered its drilling and completions capital budget to $430 million to $470 million from $460 million to $490 million.
Q1 2025 total revenues were $350.3 million, compared with $319.4 million in Q1 2024.
Average daily production reached 96.5 thousand barrels of oil equivalent per day, up 14% from a year earlier.
The company repurchased 2.2 million Class A shares for $52.0 million in the quarter and declared a $0.15 per share dividend payable June 2, 2025.
Second quarter 2025 production is estimated at approximately 97 thousand barrels of oil equivalent per day.
GE HealthCare reported first quarter 2025 revenue of $4.8 billion, up 3%, and diluted EPS of $1.23 versus $0.81 a year earlier. The company also cut its full-year 2025 guidance, including adjusted EPS of $3.90 to $4.10 versus prior guidance of $4.61 to $4.75, and said the outlook includes about $0.85 of tariff impact. The Board also authorized a $1 billion share repurchase program with no expiration date.
Q1 2025 revenue $4.8 billion, up 3% reported and 4% organic; diluted EPS $1.23 versus $0.81; adjusted EPS $1.01 versus $0.90
2025 adjusted EPS guidance lowered to $3.90-$4.10 from $4.61-$4.75, including about $0.85 of tariff impact
Free cash flow guidance lowered to at least $1.2 billion from at least $1.75 billion; Q1 free cash flow was $98 million versus $274 million
Board authorized up to $1 billion in share repurchases with no expiration date
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.